{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:00:58Z","timestamp":1793109658408,"version":"4.5.0"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["RS-2024\\u201300460411"],"award-info":[{"award-number":["RS-2024\\u201300460411"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["2025-RISE-11\\u2013014\\u201303"],"award-info":[{"award-number":["2025-RISE-11\\u2013014\\u201303"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025\\u201302273102"],"award-info":[{"award-number":["RS-2025\\u201302273102"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118931","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:34:21Z","timestamp":1767681261000},"page":"118931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Multifaceted role of interleukin-32 in inflammatory diseases and cancer"],"prefix":"10.1016","volume":"194","author":[{"given":"Sun Mi","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Moon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik Ho","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Bae","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seok","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6534-9575","authenticated-orcid":false,"given":"Jin Tae","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118931_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837588","article-title":"Comparison of the seven interleukin-32 Isoforms' Biological Activities: IL-32\u03b8 possesses the most dominant biological activity","volume":"13","author":"Shim","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib2","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.1038\/s41598-024-58550-5","article-title":"Pan-cancer analysis reveals IL32 is a potential prognostic and immunotherapeutic biomarker in cancer","volume":"14","author":"Han","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2011.12.023","article-title":"Dysregulation of overexpressed IL-32\u03b1 in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-\u03baB and Bcl-2","volume":"318","author":"Kang","year":"2012","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2025.118931_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41419-019-1737-4","article-title":"IL-32\u03b3 suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway","volume":"10","author":"Lee","year":"2019","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/biof.2005","article-title":"Modulatory effects of point-mutated IL-32\u03b8 (A94V) on tumor progression in triple-negative breast cancer cells","volume":"50","author":"Park","year":"2024","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12964-019-0374-y","article-title":"Interleukin-32\u03b8 inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer","volume":"17","author":"Pham","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2025.118931_bib7","first-page":"41","article-title":"Role of interleukin-32 in cancer biology","author":"Yan","year":"2018","journal-title":"Oncol. Lett. 16(1"},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/ar4089","article-title":"IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis","volume":"14","author":"Moon","year":"2012","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12967-022-03375-x","article-title":"IL-32 promotes the occurrence of atopic dermatitis by activating the JAK1\/microRNA-155 axis","volume":"20","author":"Chang","year":"2022","journal-title":"J. Transl. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","article-title":"IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis","volume":"125","author":"Meyer","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12931-018-0832-x","article-title":"Interleukin-32: its role in asthma and potential as a therapeutic agent","volume":"19","author":"Xin","year":"2018","journal-title":"Respir. Res"},{"issue":"10","key":"10.1016\/j.biopha.2025.118931_bib12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/gutjnl-2019-319226","article-title":"Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker","volume":"69","author":"Baselli","year":"2020","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/hep4.1396","article-title":"Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance","volume":"3","author":"Dali-Youcef","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2025.118931_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jir.2020.0230","article-title":"Interleukin-32 in pathogenesis of atopic diseases: proinflammatory or anti-inflammatory role?","volume":"41","author":"Boreika","year":"2021","journal-title":"J. Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib15","doi-asserted-by":"crossref","first-page":"12092","DOI":"10.1038\/s41598-020-69000-3","article-title":"Correlation between serum IL-32 concentration and clinical parameters of stable COPD: a retrospective clinical analysis","volume":"10","author":"Rong","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","article-title":"Epithelial overexpression of interleukin-32\u03b1 in inflammatory bowel disease","volume":"149","author":"Shioya","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/08923973.2022.2138430","article-title":"Impact of interleukin-32\u03b1 on T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus","volume":"45","author":"Borzouei","year":"2023","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.biopha.2025.118931_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154832","article-title":"Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-\u03b1 and IL-6","volume":"125","author":"Fadaei","year":"2020","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.biopha.2025.118931_bib19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4049\/jimmunol.2200087","article-title":"Inhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection","volume":"209","author":"Nasser","year":"2022","journal-title":"J. Immunol."},{"issue":"D1","key":"10.1016\/j.biopha.2025.118931_bib20","doi-asserted-by":"crossref","first-page":"D1302","DOI":"10.1093\/nar\/gkaa1027","article-title":"Open targets platform: supporting systematic drug-target identification and prioritisation","volume":"49","author":"Ochoa","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.biopha.2025.118931_bib21","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib22","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/dxh339","article-title":"Involvement of IL-32 in activation-induced cell death in T cells","volume":"18","author":"Goda","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2025.118931_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biochi.2014.01.013","article-title":"Interaction network mapping among IL-32 isoforms","volume":"101","author":"Kang","year":"2014","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","article-title":"Molecular interactions and functions of IL-32","volume":"109","author":"Aass","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/ar2074","article-title":"Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases","volume":"8","author":"Shoda","year":"2006","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2567.2011.03513.x","article-title":"Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3","volume":"135","author":"Park","year":"2012","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.biopha.2025.118931_bib28","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.4049\/jimmunol.1100277","article-title":"The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection","volume":"186","author":"Smith","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118931_bib29","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1128\/JVI.00168-15","article-title":"Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase C\u03b4 Pathway","volume":"89","author":"Lai","year":"2015","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3109\/02713683.2012.763102","article-title":"TLR-mediated Induction of Proinflammatory Cytokine IL-32 in Corneal Epithelium","volume":"38","author":"Zhang","year":"2013","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biopha.2025.118931_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2018.02.027","article-title":"Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes","volume":"271","author":"Damen","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cyto.2013.05.002","article-title":"Towards a role of interleukin-32 in atherosclerosis","volume":"64","author":"Heinhuis","year":"2013","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","article-title":"Molecular characterization of IL-32 in human endothelial cells","volume":"46","author":"Kobayashi","year":"2009","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2567.2010.03377.x","article-title":"Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene","volume":"132","author":"Lee","year":"2011","journal-title":"Immunology"},{"issue":"2 Pt B","key":"10.1016\/j.biopha.2025.118931_bib35","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.canlet.2014.10.030","article-title":"Hypoxia-induced IL-32\u03b2 increases glycolysis in breast cancer cells","volume":"356","author":"Park","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2010.09.002","article-title":"Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein","volume":"53","author":"Hasegawa","year":"2011","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.biopha.2025.118931_bib37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/intimm\/dxn055","article-title":"Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS","volume":"20","author":"Selleri","year":"2008","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cyto.2012.09.022","article-title":"Expression of IL-32 modulates NF-\u03baB and p38 MAP kinase pathways in human esophageal cancer","volume":"61","author":"Yousif","year":"2013","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001985","article-title":"Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection","volume":"3","author":"Li","year":"2008","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib40","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","article-title":"IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12967-019-1862-y","article-title":"Interleukin 32 expression in human melanoma","volume":"17","author":"Paz","year":"2019","journal-title":"J. Transl. Med"},{"issue":"41","key":"10.1016\/j.biopha.2025.118931_bib42","doi-asserted-by":"crossref","first-page":"69833","DOI":"10.18632\/oncotarget.19311","article-title":"Von Hippel-Lindau regulates interleukin-32\u03b2 stability in ovarian cancer cells","volume":"8","author":"Yong","year":"2017","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/j.biopha.2025.118931_bib43","doi-asserted-by":"crossref","first-page":"17868","DOI":"10.1074\/jbc.M900368200","article-title":"Interleukin-32 expression in the pancreas","volume":"284","author":"Nishida","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib44","doi-asserted-by":"crossref","first-page":"G831","DOI":"10.1152\/ajpgi.00535.2007","article-title":"Phosphatidylinositol 3-kinase\/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts","volume":"294","author":"Nishida","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"24","key":"10.1016\/j.biopha.2025.118931_bib45","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1002\/cncr.25488","article-title":"MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer","volume":"116","author":"Majid","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib46","first-page":"263","article-title":"Y. Fujiyama, Interleukin-32\u03b1 expression in human colonic subepithelial myofibroblasts","volume":"27","author":"Yagi","year":"2011","journal-title":"Int J. Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","article-title":"Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease","volume":"149","author":"Shioya","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118931_bib48","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1073\/pnas.1016005108","article-title":"Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis","volume":"108","author":"Heinhuis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tcb.2016.11.007","article-title":"Pathways of unconventional protein secretion","volume":"27","author":"Rabouille","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","article-title":"Identification of a novel gene expressed in activated natural killer cells and T cells","volume":"148","author":"Dahl","year":"1992","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118931_bib51","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.bbapap.2006.07.002","article-title":"Protein sulfation analysis--A primer","volume":"1764","author":"Monigatti","year":"2006","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118931_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0083-6729(06)74008-0","article-title":"The newest interleukins: recent additions to the ever-growing cytokine family","volume":"74","author":"Chen","year":"2006","journal-title":"Vitam. Horm."},{"issue":"17","key":"10.1016\/j.biopha.2025.118931_bib53","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.89.17.8215","article-title":"Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter","volume":"89","author":"Zimmer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0014-5793(99)01098-4","article-title":"Proteinase 3 mRNA expression is induced in monocytes but not in neutrophils of patients with cystic fibrosis","volume":"457","author":"Just","year":"1999","journal-title":"FEBS Lett."},{"issue":"54","key":"10.1016\/j.biopha.2025.118931_bib55","doi-asserted-by":"crossref","first-page":"92841","DOI":"10.18632\/oncotarget.21611","article-title":"Interleukin-32\u03b1 promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar410","article-title":"Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis","volume":"4","author":"Brockmann","year":"2002","journal-title":"Arthritis Res"},{"issue":"12","key":"10.1016\/j.biopha.2025.118931_bib57","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2007-03-080457","article-title":"Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis","volume":"110","author":"Kantari","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biopha.2025.118931_bib58","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1074\/jbc.M111.288290","article-title":"Interleukin 32 (IL-32) contains a typical \u03b1-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1","volume":"287","author":"Heinhuis","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9090116","article-title":"Exploring the role of RGD-recognizing integrins in cancer","volume":"9","author":"Nieberler","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib60","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1078-0432.CCR-13-1221","article-title":"Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis","volume":"20","author":"Tsai","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118931_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","article-title":"Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling","volume":"442","author":"Wen","year":"2019","journal-title":"Cancer Lett."},{"issue":"33","key":"10.1016\/j.biopha.2025.118931_bib62","doi-asserted-by":"crossref","first-page":"23650","DOI":"10.1074\/jbc.M113.465575","article-title":"Interleukin (IL)-32\u03b2-mediated CCAAT\/enhancer-binding protein \u03b1 (C\/EBP\u03b1) phosphorylation by protein kinase C\u03b4 (PKC\u03b4) abrogates the inhibitory effect of C\/EBP\u03b1 on IL-10 production","volume":"288","author":"Kang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2025.118931_bib63","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cellsig.2014.03.027","article-title":"IL-32\u03b1 down-regulates \u03b22 integrin (CD18) expression by suppressing PU.1 expression in myeloid cells","volume":"26","author":"Kang","year":"2014","journal-title":"Cell Signal"},{"issue":"42","key":"10.1016\/j.biopha.2025.118931_bib64","doi-asserted-by":"crossref","first-page":"35556","DOI":"10.1074\/jbc.M112.400911","article-title":"Intracellular interaction of interleukin (IL)-32\u03b1 with protein kinase C\u03b5 (PKC\u03b5) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells","volume":"287","author":"Kang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2025.118931_bib65","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.cellsig.2014.09.015","article-title":"IL-32\u03b8 downregulates CCL5 expression through its interaction with PKC\u03b4 and STAT3","volume":"26","author":"Bak","year":"2014","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.biopha.2025.118931_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081949","article-title":"Inhibition of IL-13 and IL-13R\u03b12 expression by il-32\u03b8 in human monocytic cells requires PKC\u03b4 and STAT3 association","volume":"20","author":"Pham","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118931_bib67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-065X.2008.00648.x","article-title":"The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis","volume":"223","author":"Noss","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2025.118931_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1140373","article-title":"Interleukin-32 as a biomarker in rheumatic diseases: A narrative review","volume":"14","author":"Kwon","year":"2023","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib69","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1073\/pnas.0511233103","article-title":"IL-32, a proinflammatory cytokine in rheumatoid arthritis","volume":"103","author":"Joosten","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.biopha.2025.118931_bib70","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.4049\/jimmunol.1003996","article-title":"IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production","volume":"186","author":"Jung","year":"2011","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/ar3073","article-title":"Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis","volume":"12","author":"Alsaleh","year":"2010","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib72","article-title":"A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10","volume":"128","author":"Kang","year":"2009","journal-title":"Immunology"},{"issue":"36","key":"10.1016\/j.biopha.2025.118931_bib73","doi-asserted-by":"crossref","first-page":"38566","DOI":"10.18632\/oncotarget.6160","article-title":"Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32beta overexpressed transgenic mice","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118931_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004173","article-title":"Interleukin-32 promotes osteoclast differentiation but not osteoclast activation","volume":"4","author":"Mabilleau","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib76","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.27197","article-title":"Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13012","article-title":"The role of Interleukin-32 in autoimmunity","volume":"93","author":"de Albuquerque","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"21","key":"10.1016\/j.biopha.2025.118931_bib78","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.3748\/wjg.v20.i21.6457","article-title":"Virus-related liver cirrhosis: molecular basis and therapeutic options","volume":"20","author":"Lin","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118931_bib79","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.7326\/M20-7466","article-title":"Alcohol sales and alcohol-related emergencies during the COVID-19 pandemic","volume":"174","author":"Zipursky","year":"2021","journal-title":"Ann. Intern Med"},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib80","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/hep4.1747","article-title":"Alcohol-associated liver disease before and after COVID-19-An overview and call for ongoing investigation","volume":"5","author":"Moon","year":"2021","journal-title":"Hepatol. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib81","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","article-title":"Natural history of histologically proven alcohol-related liver disease: a systematic review","volume":"71","author":"Parker","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2023.110735","article-title":"Single-cell transcriptomics of peripheral blood mononuclear cells indicates impaired immune and inflammatory responses in alcohol-associated hepatitis","volume":"85","author":"Liu","year":"2024","journal-title":"Hum. Immunol."},{"issue":"17","key":"10.1016\/j.biopha.2025.118931_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713222","article-title":"Saturated fat-mediated upregulation of IL-32 and CCL20 in hepatocytes contributes to higher expression of these fibrosis-driving molecules in MASLD","volume":"24","author":"Schilcher","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118931_bib84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fcimb.2020.00135","article-title":"Marmoset viral hepatic inflammation induced by hepatitis C virus core protein via IL-32","volume":"10","author":"Liu","year":"2020","journal-title":"Front Cell Infect. Microbiol"},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib85","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2025.118931_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.594","article-title":"A novel role for interleukin 32 in cholestasis","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib87","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/1751-2980.13196","article-title":"Hepatic interleukin 32 attenuates liver injury through repression of necroptosis in cholestasis","volume":"24","author":"Mao","year":"2023","journal-title":"J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib88","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3138\/canlivj.2018-0003","article-title":"Circulating and inducible IL-32\u03b1 in chronic hepatitis C virus infection","volume":"2","author":"Collister","year":"2019","journal-title":"Can. Liver J."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/oby.21001","article-title":"Interleukin-32\u03b2 ameliorates metabolic disorder and liver damage in mice fed high-fat diet","volume":"23","author":"Lee","year":"2015","journal-title":"Obes. (Silver Spring)"},{"issue":"10","key":"10.1016\/j.biopha.2025.118931_bib90","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/CS20140576","article-title":"Interleukin-32\u03b3 attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses","volume":"128","author":"Lee","year":"2015","journal-title":"Clin. Sci. (Lond. )"},{"issue":"7","key":"10.1016\/j.biopha.2025.118931_bib91","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.4049\/jimmunol.1000081","article-title":"Protection from RNA and DNA viruses by IL-32","volume":"186","author":"Zepp","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib92","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2011.12.024","article-title":"Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection","volume":"58","author":"Bae","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","article-title":"Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication","volume":"117","author":"Rasool","year":"2008","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib94","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","article-title":"Endogenous IL-32 controls cytokine and HIV-1 production","volume":"181","author":"Nold","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib95","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/eji.200838885","article-title":"Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection","volume":"39","author":"Li","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"29","key":"10.1016\/j.biopha.2025.118931_bib96","doi-asserted-by":"crossref","first-page":"20927","DOI":"10.1074\/jbc.M112.440115","article-title":"Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon \u03bb1 (IFN-\u03bb1)","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2025.118931_bib97","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0962-8924(98)01273-2","article-title":"The central executioners of apoptosis: caspases or mitochondria?","volume":"8","author":"Green","year":"1998","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib98","first-page":"1155","article-title":"Overexpression of interleukin-32\u03b1 promotes invasion by modulating VEGF in hepatocellular carcinoma","volume":"39","author":"Zhao","year":"2018","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib99","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5483\/BMBRep.2019.52.3.019","article-title":"Interleukin-32: Frenemy in cancer?","volume":"52","author":"Han","year":"2019","journal-title":"BMB Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000524977","article-title":"Combination Immunotherapy with Anti-PD-1\/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass","volume":"11","author":"Kudo","year":"2022","journal-title":"Liver Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib101","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/187152812800959022","article-title":"Allergen-specific responses of CD19(high) and CD19(low) B Cells in Non-IgE-mediated food allergy of late eczematous reactions in atopic dermatitis: presence of IL-17- and IL-32-producing regulatory B cells (Br17 & Br32)","volume":"11","author":"Noh","year":"2012","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"5","key":"10.1016\/j.biopha.2025.118931_bib102","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/jid.2013.488","article-title":"The role of IL-32 in cutaneous T-cell lymphoma","volume":"134","author":"Suga","year":"2014","journal-title":"J. Invest Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib103","first-page":"865","article-title":"IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells","volume":"20","author":"Kempuraj","year":"2010","journal-title":"Eur. J. Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib104","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1535370213477975","article-title":"Rutin suppresses atopic dermatitis and allergic contact dermatitis","volume":"238","author":"Choi","year":"2013","journal-title":"Exp. Biol. Med (Maywood)"},{"issue":"10","key":"10.1016\/j.biopha.2025.118931_bib105","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/jdv.14274","article-title":"Decrease in serum IL-32 level in patients with atopic dermatitis after cyclosporine treatment, J Eur","volume":"31","author":"Kitayama","year":"2017","journal-title":"Acad. Dermatol. Venereol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118931_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138772","article-title":"IL-32\u03b3 potentiates tumor immunity in melanoma","volume":"5","author":"Gruber","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib107","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.2650","article-title":"NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib108","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaci.2019.12.905","article-title":"IL-32\u03b3 suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B","volume":"146","author":"Lee","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjd.16721","article-title":"Interleukin-32 promotes detachment and activation of human Langerhans cells in a human skin explant model","volume":"179","author":"Gonnet","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib110","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4049\/jimmunol.1601477","article-title":"Dendritic Cell-Derived IL-32\u03b1: a novel inhibitory cytokine of NK cell function","volume":"199","author":"Gorvel","year":"2017","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib111","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2011.12.1002","article-title":"Inhibition of angiogenesis by IL-32: possible role in asthma","volume":"129","author":"Meyer","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118931_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114012","article-title":"Promises and challenges of biologics for severe asthma","volume":"179","author":"Tan","year":"2020","journal-title":"Biochem Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib113","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1165\/rcmb.2013-0234OC","article-title":"Interleukin-32\u03b3 suppresses allergic airway inflammation in mouse models of asthma","volume":"50","author":"Bang","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib114","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12931-018-0863-3","article-title":"IL-32\u03b3 attenuates airway fibrosis by modulating the integrin-FAK signaling pathway in fibroblasts","volume":"19","author":"Hong","year":"2018","journal-title":"Respir. Res"},{"key":"10.1016\/j.biopha.2025.118931_bib115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2018.03.004","article-title":"Insights into the role of IL-32 in cancer","volume":"38","author":"Sloot","year":"2018","journal-title":"Semin Immunol."},{"key":"10.1016\/j.biopha.2025.118931_bib116","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.02.025","article-title":"Interleukin 32, inflammation and cancer","volume":"174","author":"Hong","year":"2017","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118931_bib117","first-page":"397","article-title":"Cytokine inhibition in the treatment of COPD","volume":"9","author":"Caramori","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon Dis."},{"issue":"36","key":"10.1016\/j.biopha.2025.118931_bib118","doi-asserted-by":"crossref","first-page":"38566","DOI":"10.18632\/oncotarget.6160","article-title":"Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32\u03b2 overexpressed transgenic mice","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118931_bib119","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12957-015-0552-3","article-title":"Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis","volume":"13","author":"Yang","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2025.118931_bib120","first-page":"78","article-title":"Interleukin-21 and Interleukin-32 gene expression levels and their relationship with clinicopathological parameters in colorectal cancer","volume":"92","author":"Ozmen","year":"2022","journal-title":"Ann. Ital. Chir."},{"key":"10.1016\/j.biopha.2025.118931_bib121","first-page":"4655","article-title":"IL-32 expression indicates unfavorable prognosis in patients with colon cancer","author":"Zhai","year":"2019","journal-title":"Oncol. Lett. 17(5"},{"key":"10.1016\/j.biopha.2025.118931_bib122","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1328338","article-title":"IL-32\u03b1-induced inflammation constitutes a link between obesity and colon cancer","author":"Catal\u00e1n","year":"2017","journal-title":"Oncoimmunology 6(7"},{"issue":"11","key":"10.1016\/j.biopha.2025.118931_bib123","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.18632\/oncotarget.3197","article-title":"IL-32\u03b1 suppresses colorectal cancer development via TNFR1-mediated death signaling","volume":"6","author":"Yun","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib124","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.MIB.0000163698.34592.30","article-title":"Differential role of tumor necrosis factor receptors in TNBS colitis","volume":"11","author":"Ebach","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118931_bib125","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.166","article-title":"Antitumor activity of IL-32\u03b2 through the activation of lymphocytes, and the inactivation of NF-\u03baB and STAT3 signals","volume":"4","author":"Yun","year":"2013","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib126","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.18632\/oncotarget.7007","article-title":"IL-32\u03b8 inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer","volume":"7","author":"Bak","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib127","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/1354750X.2016.1252956","article-title":"Polymorphisms and expression of IL-32: impact on genetic susceptibility and clinical outcome of lung cancer","volume":"22","author":"Wang","year":"2017","journal-title":"Biomarkers"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00795-023-00378-5","article-title":"IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment","volume":"57","author":"Zhao","year":"2024","journal-title":"Med Mol. Morphol."},{"key":"10.1016\/j.biopha.2025.118931_bib129","first-page":"6653747","article-title":"IL-32 promotes the radiosensitivity of esophageal squamous cell carcinoma cell through STAT3 pathway","author":"Ma","year":"2021","journal-title":"Biomed. Res Int 2021"},{"issue":"8","key":"10.1016\/j.biopha.2025.118931_bib130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","article-title":"Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype","volume":"180","author":"Sorrentino","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cyto.2008.01.004","article-title":"Unique expression of a small IL-32 protein in the Jurkat leukemic T cell line","volume":"42","author":"Ko","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2025.118931_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104652","article-title":"Diverse and divergent functions of IL-32\u03b2 and IL-32\u03b3 isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8","volume":"383","author":"Numasaki","year":"2023","journal-title":"Cell Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib133","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2013.09.017","article-title":"Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression","volume":"65","author":"Zeng","year":"2014","journal-title":"Cytokine"},{"issue":"40","key":"10.1016\/j.biopha.2025.118931_bib134","doi-asserted-by":"crossref","first-page":"65825","DOI":"10.18632\/oncotarget.11669","article-title":"Interleukin-32\u03b1 induces migration of human melanoma cells through downregulation of E-cadherin","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41419-018-0375-6","article-title":"IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation","volume":"9","author":"Yun","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib136","first-page":"1606","article-title":"Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining","volume":"18","author":"Seo","year":"2008","journal-title":"J. Microbiol. Biotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib137","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4251\/wjgo.v14.i9.1808","article-title":"Clinical implications of interleukins-31, 32, and 33 in gastric cancer","volume":"14","author":"Liu","year":"2022","journal-title":"World J. Gastrointest. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib138","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12032-013-0472-4","article-title":"IL-32 expression is an independent prognostic marker for gastric cancer","volume":"30","author":"Ishigami","year":"2013","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118931_bib139","article-title":"Local and systemic Interleukin-32 in esophageal, gastric, and colorectal cancers: clinical and diagnostic significance","volume":"10","author":"Diakowska","year":"2020","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.biopha.2025.118931_bib140","doi-asserted-by":"crossref","first-page":"6697597","DOI":"10.1155\/2021\/6697597","article-title":"Analysis of intestinal flora and levels of epidermal growth factor receptor, Interleukin-32, and Gastrin 17 in patients with gastric cancer via carbon nanoparticle laparoscopy","volume":"2021","author":"Bai","year":"2021","journal-title":"Biomed. Res Int"},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib141","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1007\/s12010-023-04782-6","article-title":"Cancer-associated fibroblast-secreted exosomes promote gastric cancer cell migration and invasion via the IL-32\/ESR1 axis","volume":"196","author":"Shang","year":"2024","journal-title":"Appl. Biochem Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib142","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3892\/ol.2015.3950","article-title":"Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma","volume":"11","author":"Cui","year":"2016","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2025.118931_bib143","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/IAI.00637-12","article-title":"Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation","volume":"80","author":"Sakitani","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2025.118931_bib144","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fmicb.2020.00880","article-title":"Integrative analysis of differential lncRNA\/mRNA expression profiling in helicobacter pylori infection-associated gastric carcinogenesis","volume":"11","author":"Li","year":"2020","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib145","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e27","article-title":"Recombinant human IL-32\u03b8 induces polarization Into M1-like macrophage in human monocytic cells","volume":"24","author":"Park","year":"2024","journal-title":"Immune Netw."},{"issue":"6","key":"10.1016\/j.biopha.2025.118931_bib146","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s13402-013-0154-4","article-title":"Interleukin-32\u03b2 stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway","volume":"36","author":"Park","year":"2013","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib147","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00383-023-05557-0","article-title":"Potential involvement of IL-32 in cell-to-cell communication between macrophages and hepatoblastoma","volume":"39","author":"Adawy","year":"2023","journal-title":"Pedia Surg. Int"},{"key":"10.1016\/j.biopha.2025.118931_bib148","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.2147\/OTT.S103581","article-title":"Interleukin-32\u03b1 inactivates JAK2\/STAT3 signaling and reverses interleukin-6-induced epithelial\u2013mesenchymal transition, invasion, and metastasis in pancreatic cancer cells","volume":"9","author":"Chen","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib149","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3892\/ol.2020.11825","article-title":"Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32","volume":"20","author":"Takagi","year":"2020","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/ol.2021.13132","article-title":"Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells","volume":"23","author":"Takagi","year":"2022","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib151","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2057837","article-title":"Myeloma-derived IL-32\u03b3 induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"issue":"14","key":"10.1016\/j.biopha.2025.118931_bib152","doi-asserted-by":"crossref","first-page":"12049","DOI":"10.1074\/jbc.M110.159756","article-title":"Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells","volume":"286","author":"Cheon","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib153","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jso.24142","article-title":"IL-32\u03b1 has differential effects on proliferation and apoptosis of human melanoma cell lines","volume":"113","author":"Nicholl","year":"2016","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib154","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13046-018-0943-8","article-title":"Inhibition of skin carcinogenesis by suppression of NF-\u03baB dependent ITGAV and TIMP-1 expression in IL-32\u03b3 overexpressed condition","volume":"37","author":"Lee","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118931_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.704853","article-title":"Interleukin 32 Promotes Foxp3(+) Treg cell development and CD8(+) T cell function in human esophageal squamous cell carcinoma microenvironment","volume":"9","author":"Han","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib156","first-page":"E23","article-title":"IL-32\u03b3 enhances TNF-\u03b1-induced cell death in colon cancer","volume":"53","author":"Park","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"30","key":"10.1016\/j.biopha.2025.118931_bib157","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/onc.2011.52","article-title":"IL-32\u03b3 inhibits cancer cell growth through inactivation of NF-\u03baB and STAT3 signals","volume":"30","author":"Oh","year":"2011","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2025.118931_bib158","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.3892\/etm.2017.4956","article-title":"IL-32\u03b3 promotes integrin \u03b1v\u03b26 expression through the activation of NF-\u03baB in HSCs","volume":"14","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2025.118931_bib159","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2019.01.012","article-title":"Multiple myeloma cell-derived IL-32\u03b3 increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression","volume":"446","author":"Yan","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-022-02348-8","article-title":"Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK\/STAT3 pathway","volume":"41","author":"Sun","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib161","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/jcmm.14794","article-title":"MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32\/AKT signalling pathway","volume":"24","author":"He","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2025.118931_bib162","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","article-title":"IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease","volume":"178","author":"Calabrese","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2025.118931_bib163","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2017.07.005","article-title":"Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases","volume":"264","author":"Damen","year":"2017","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib164","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4049\/jimmunol.1202802","article-title":"IL-32 promotes angiogenesis","volume":"192","author":"Nold-Petry","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009458","article-title":"Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model","volume":"5","author":"Kobayashi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118931_bib166","doi-asserted-by":"crossref","first-page":"1160301","DOI":"10.3389\/fimmu.2023.1160301","article-title":"Human IL-32\u03b8A94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin \u03b1V\u03b23 and \u03b1V\u03b26 in TNF-\u03b1-stimulated HUVECs","volume":"14","author":"Park","year":"2023","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24114","article-title":"Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease","volume":"36","author":"Jin","year":"2022","journal-title":"J. Clin. Lab Anal."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/v15030700","article-title":"Differential impact of IL-32 isoforms on the functions of coronary artery endothelial cells: a potential link with arterial stiffness and atherosclerosis","volume":"15","author":"Bunet","year":"2023","journal-title":"Viruses"},{"issue":"49","key":"10.1016\/j.biopha.2025.118931_bib169","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1073\/pnas.1015418107","article-title":"Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis","volume":"107","author":"Choi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088270","article-title":"Elevated Interleukin-32 expression is associated with helicobacter pylori-related gastritis","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS ONE"},{"issue":"45","key":"10.1016\/j.biopha.2025.118931_bib171","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism","volume":"102","author":"Netea","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib172","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2010.09.099","article-title":"The effects of IL-32 on the inflammatory activation of cultured rat primary astrocytes","volume":"402","author":"Cho","year":"2010","journal-title":"Biochem Biophys. Res Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib173","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-8739-0","article-title":"Reducing effect of IL-32alpha in the development of stroke through blocking of NF-kappaB, but enhancement of STAT3 pathways","volume":"51","author":"Hwang","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118931_bib174","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00415-011-6036-7","article-title":"Elevated serum level of interleukin-32\u03b1 in the patients with myasthenia gravis","volume":"258","author":"Na","year":"2011","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118931_bib175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10875-012-9837-2","article-title":"Increased plasma interleukin-32 expression in patients with neuromyelitis optica","volume":"33","author":"Wang","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"38","key":"10.1016\/j.biopha.2025.118931_bib176","doi-asserted-by":"crossref","first-page":"40452","DOI":"10.18632\/oncotarget.6306","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice","volume":"6","author":"Yun","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118931_bib177","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuint.2016.12.002","article-title":"Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32\u03b2 transgenic mice","volume":"102","author":"Jung","year":"2017","journal-title":"Neurochem. Int"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib178","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/clinem\/dgad531","article-title":"Increased circulating IL-32 is associated with placenta macrophage-derived IL-32 and gestational diabetes mellitus","volume":"109","author":"Huang","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103605","article-title":"Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells","volume":"25","author":"Aass","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2025.118931_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154793","article-title":"Transgenic mice expressing human IL-32 develop adipokine profiles resembling those of obesity-induced metabolic changes","volume":"125","author":"Damen","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2014.05.002","article-title":"IL-32\u03b3 overexpression accelerates streptozotocin (STZ)-induced type 1 diabetes","volume":"69","author":"Jhun","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2025.118931_bib182","first-page":"8413768","article-title":"IL-32: a novel pluripotent inflammatory interleukin, towards gastric inflammation, gastric cancer, and chronic Rhino Sinusitis","author":"Khawar","year":"2016","journal-title":"Mediat. Inflamm. 2016"},{"issue":"12","key":"10.1016\/j.biopha.2025.118931_bib183","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.celrep.2015.08.041","article-title":"Cocaine-induced endocannabinoid mobilization in the ventral tegmental area","volume":"12","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib184","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3892\/ol.2014.2641","article-title":"IL-32 promotes breast cancer cell growth and invasiveness","volume":"9","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118931_bib185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cyto.2012.09.022","article-title":"Expression of IL-32 modulates NF-\u03baB and p38 MAP kinase pathways in human esophageal cancer","volume":"61","author":"Yousif","year":"2013","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.biopha.2025.118931_bib186","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jid.2022.01.009","article-title":"IL-32 supports the survival of malignant T cells in cutaneous T-cell Lymphoma","volume":"142","author":"Yu","year":"2022","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib187","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2011.12.023","article-title":"Dysregulation of overexpressed IL-32\u03b1 in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-\u03baB and Bcl-2","volume":"318","author":"Kang","year":"2012","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2025.118931_bib188","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/carcin\/bgt092","article-title":"A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell\u2013derived thyroid carcinoma","volume":"34","author":"Plantinga","year":"2013","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.biopha.2025.118931_bib189","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/carcin\/bgv172","article-title":"Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines","volume":"37","author":"Heinhuis","year":"2016","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.biopha.2025.118931_bib190","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s13402-019-00457-9","article-title":"Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration","volume":"42","author":"Sloot","year":"2019","journal-title":"Cell Oncol (Dordr)"},{"issue":"5","key":"10.1016\/j.biopha.2025.118931_bib191","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s13577-024-01094-7","article-title":"IL-32\/NF\u03baB\/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells","volume":"37","author":"Liu","year":"2024","journal-title":"Hum. Cell"},{"issue":"20","key":"10.1016\/j.biopha.2025.118931_bib192","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10204691","article-title":"Prognostic Value of Interleukin-32 Expression and Its Correlation with the Infiltration of Natural Killer Cells in Cutaneous Melanoma","volume":"10","author":"Kang","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.118931_bib193","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.2147\/OTT.S103581","article-title":"Interleukin-32\u03b1 inactivates JAK2\/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells","volume":"9","author":"Chen","year":"2016","journal-title":"Onco Targets Ther."},{"issue":"18","key":"10.1016\/j.biopha.2025.118931_bib194","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.18632\/oncotarget.2364","article-title":"Interleukin-32\u03b1 downregulates the activity of the B-cell CLL\/lymphoma 6 protein by inhibiting protein kinase C\u03b5-dependent SUMO-2 modification","volume":"5","author":"Park","year":"2014","journal-title":"Oncotarget"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:47:17Z","timestamp":1777574837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":194,"alternative-id":["S0753332225011254"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118931","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifaceted role of interleukin-32 in inflammatory diseases and cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118931"}}